Home » Topics » Regulatory » EMA

EMA
RSS

Roche files to extend indication of tocilizumab for systemic juvenile idiopathic arthritis

Oct. 21, 2010

EC grants orphan drug status for eflornithine in familial adenomatous polyposis

Oct. 21, 2010

EC grants orphan drug status for S*BIO's SB-1518 in myelofibrosis

Oct. 20, 2010

EMA recommends approval of CTI's pediatric investigation plan for Pixuvri

Oct. 20, 2010

European orphan drug status for recombinant porcine factor VIII in hemophilia A

Oct. 20, 2010

EMA grants orphan drug status for forodesine in chronic lymphocytic leukemia

Oct. 19, 2010

EC grants orphan drug status for pralatrexate in Hodgkin's lymphoma

Oct. 19, 2010

European orphan drug status for NeuroSTAT in traumatic brain injury

Oct. 18, 2010

EMA approves Twynsta single pill combination for high blood pressure

Oct. 14, 2010

Tesetaxel receives EMA orphan drug status for gastric cancer

Oct. 14, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 7, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 7, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.